[190] showed that the transcriptional regulators ETS1 and RUNX1 act as drivers of NASH-associated hepatic stellate cell activation and transcriptional plasticity, key aspects of NASH pathophysiology. The gene discussed is RUNX1; the disease is metabolic dysfunction-associated steatohepatitis.